The following data is part of a premarket notification filed by Quest Intl., Inc. with the FDA for Seraquest Anti-thyroglobulin.
Device ID | K023592 |
510k Number | K023592 |
Device Name: | SERAQUEST ANTI-THYROGLOBULIN |
Classification | Thyroglobulin, Antigen, Antiserum, Control |
Applicant | QUEST INTL., INC. 1938 N.E. 148TH TERR. North Miami, FL 33181 |
Contact | Robert A Cort |
Correspondent | Robert A Cort QUEST INTL., INC. 1938 N.E. 148TH TERR. North Miami, FL 33181 |
Product Code | DDC |
CFR Regulation Number | 866.5870 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-10-25 |
Decision Date | 2003-01-06 |
Summary: | summary |